Target intelligence / Profile preview

Ribosomal protein L12 pseudogene 38 (RPL12P38)

Target: RPL12P38
Molecular classification: Other

Overview

Ribosomal protein L12 pseudogene 38 (RPL12P38) is a processed pseudogene, not encoding a protein product, related by sequence homology to the gene for ribosomal protein L12, a structural component of the large (60S) ribosomal subunit involved in protein synthesis. Pseudogenes such as RPL12P38 are typically considered non-functional remnants and do not have known biological functions, direct disease associations, protein products, or clinical relevance as therapeutic targets[1][6].

Other names: RPL12P38

Beyond the preview

Go deeper on Ribosomal protein L12 pseudogene 38 (RPL12P38).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L12 pseudogene 38 (RPL12P38).

Explore the full profile